Antineoplastic agents.

Anticancer drug development by: (Language materials, printed)

Cancer targeted drug delivery = an elusive dream / by: (Language materials, printed)

Therapeutic kinase inhibitors by: (Language materials, printed)

Role of cancer stem cells in cancer biology and therapy by: (Language materials, printed)

Anti-cancer N-heterocyclic carbene complexes of gold(III), gold(I) and platinum(II) = thiol "switch-on" fluorescent probes, thioredoxin reductase inhibitors and endoplasmic reticulum targeting agents / by: (Language materials, printed)

Biotechnology and production of anti-cancer compounds by: (Language materials, printed)

Antineoplastic drugs = organic syntheses / by: (Language materials, printed)

Resistance to anti-cancer therapeutics targeting receptor tyrosine kinases and downstream pathways by: (Language materials, printed)

Anticancer plants = clinical trials and nanotechnology.. Volume 3 / by: (Language materials, printed)

Anticancer plants = properties and application.. Volume 1 / by: (Language materials, printed)

Anticancer plants = mechanisms and molecular interactions.. Volume 4 / by: (Language materials, printed)

Small molecules in hematology by: (Language materials, printed)

Small molecules in oncology by: (Language materials, printed)

Dose-finding designs for early-phase cancer clinical trials = a brief guidebook to theory and practice / by: (Language materials, printed)

Nanomaterial-based drug delivery carriers for cancer therapy by: (Language materials, printed)

Cancer chemotherapy, immunotherapy, and biotherapy = principles and practice / by: (Language materials, printed)